N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation

2025/11/01 by Raeanne M. Lanphier, Bethany D. Latham, Amanda J. Gerringer +5 · 2 voices
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Drug-Induced Hepatotoxicity and Protection #Pharmacogenetics and Drug Metabolism #Pneumocystis jirovecii pneumonia detection and treatment

paper · doi:10.1016/j.dmd.2025.100195

openalex created_date 2025/11/01 · openalex publication_date 2025/11/01 · crossref created 2025/11/01 · crossref issued 2025/12/01 · crossref published 2025/12/01 · crossref published-print 2025/12/01 · crossref deposited 2026/03/19 · crossref indexed 2026/04/02 · openalex updated_date 2026/08/01

Citations

• Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
• The PRIDE database at 20 years: 2025 update

Discussions

• Raeanne Lanphier, a 4th year PhD candidate, is the DMD Highlighted Trainee Author for December 2025. Her research focuses on understanding why a small number of patients develop unpredictable liver in [bsky, 0 points, 0 comments]
• Raeanne Lanphier, a 4th year PhD candidate, is the DMD Highlighted Trainee Author for December 2025. Her research focuses on understanding why a small number of patients develop unpredictable liver in [bsky, 0 points, 0 comments]